DE60330266D1 - Verfahren zur beurteilung der wirksamkeit von chemotherapeutika - Google Patents
Verfahren zur beurteilung der wirksamkeit von chemotherapeutikaInfo
- Publication number
- DE60330266D1 DE60330266D1 DE60330266T DE60330266T DE60330266D1 DE 60330266 D1 DE60330266 D1 DE 60330266D1 DE 60330266 T DE60330266 T DE 60330266T DE 60330266 T DE60330266 T DE 60330266T DE 60330266 D1 DE60330266 D1 DE 60330266D1
- Authority
- DE
- Germany
- Prior art keywords
- methods
- assessing
- chemotherapeutic
- effectiveness
- chemotherapeutics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41743902P | 2002-10-10 | 2002-10-10 | |
US10/336,659 US20040072722A1 (en) | 2002-10-10 | 2003-01-02 | Methods for assessing efficacy of chemotherapeutic agents |
PCT/US2003/032285 WO2004035833A1 (en) | 2002-10-10 | 2003-10-10 | Methods for assessing efficacy of chemotherapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60330266D1 true DE60330266D1 (de) | 2010-01-07 |
Family
ID=32072939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60330266T Expired - Lifetime DE60330266D1 (de) | 2002-10-10 | 2003-10-10 | Verfahren zur beurteilung der wirksamkeit von chemotherapeutika |
Country Status (6)
Country | Link |
---|---|
US (4) | US20040072722A1 (de) |
EP (1) | EP1556515B1 (de) |
AT (1) | ATE449869T1 (de) |
AU (1) | AU2003285866A1 (de) |
DE (1) | DE60330266D1 (de) |
WO (1) | WO2004035833A1 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040023375A1 (en) * | 2002-07-30 | 2004-02-05 | Precision Therapeutics, Inc. | Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays |
US20040072722A1 (en) | 2002-10-10 | 2004-04-15 | Kornblith Paul L. | Methods for assessing efficacy of chemotherapeutic agents |
US5728541A (en) * | 1996-07-12 | 1998-03-17 | Precision Therapeutics, Inc. | Method for preparing cell cultures from biologial specimens for chemotherapeutic and other assays |
US7276351B2 (en) * | 2003-09-10 | 2007-10-02 | Seahorse Bioscience | Method and device for measuring multiple physiological properties of cells |
US8658349B2 (en) * | 2006-07-13 | 2014-02-25 | Seahorse Bioscience | Cell analysis apparatus and method |
US20070087401A1 (en) * | 2003-10-17 | 2007-04-19 | Andy Neilson | Analysis of metabolic activity in cells using extracellular flux rate measurements |
US7042565B2 (en) * | 2004-02-13 | 2006-05-09 | Kaiwood Technology Co., Ltd. | Fluorescent microarray analyzer |
AU2006287175A1 (en) * | 2005-09-01 | 2007-03-08 | Precision Therapeutics, Inc. | Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics |
US8445198B2 (en) | 2005-12-01 | 2013-05-21 | Medical Prognosis Institute | Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy |
WO2007072225A2 (en) * | 2005-12-01 | 2007-06-28 | Medical Prognosis Institute | Methods and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy |
US20100216168A1 (en) * | 2007-03-23 | 2010-08-26 | Precision Therapeutics, Inc. | Methods for evaluating angiogenic potential in culture |
WO2009052159A2 (en) * | 2007-10-15 | 2009-04-23 | Precision Therapeutics, Inc. | Methods for selecting active agents for cancer treatment |
US20100311084A1 (en) * | 2008-05-14 | 2010-12-09 | Precision Therapeutics, Inc. | Methods for predicting a patient's response to egfr inhibitors |
US8202702B2 (en) * | 2008-10-14 | 2012-06-19 | Seahorse Bioscience | Method and device for measuring extracellular acidification and oxygen consumption rate with higher precision |
WO2010051552A1 (en) * | 2008-11-03 | 2010-05-06 | Precision Therapeutics, Inc. | Methods of simulating chemotherapy for a patient |
DK177532B1 (en) | 2009-09-17 | 2013-09-08 | Bio Bedst Aps | Medical use of sPLA2 hydrolysable liposomes |
US20110097748A1 (en) * | 2009-10-28 | 2011-04-28 | Warsaw Orthopedic, Inc. | Use of cell lines to determine levels of efficacy of pharmaceutical formulations |
US9598734B2 (en) | 2010-04-29 | 2017-03-21 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy |
CN104023760A (zh) | 2011-10-28 | 2014-09-03 | 普莱萨格生命科学公司 | 药物递送方法 |
JP6326058B2 (ja) | 2012-11-13 | 2018-05-16 | アジレント・テクノロジーズ・インクAgilent Technologies, Inc. | 制御された媒体流動上での三次元組織測定のための装置、インサート、および方法 |
EP2948776B8 (de) | 2013-01-25 | 2020-02-26 | Xcell Biosciences, Inc. | Verfahren, zusammensetzungen, kits und systeme zur selektiven anreicherung von zielzellen |
DE102013010528B3 (de) * | 2013-06-25 | 2014-02-20 | FLACOD GmbH | Verfahren zur Erstellung einer Datenbank für die Vorabschätzung der Wirksamkeit von Wirkstoffen in der Tumortherapie |
EP3689467A1 (de) | 2014-06-02 | 2020-08-05 | Agilent Technologies, Inc. | Einspaltiges mikroplattensystem und träger zur analyse biologischer proben |
DK3198035T3 (da) | 2014-09-26 | 2023-01-30 | Allarity Therapeutics Europe ApS | Fremgangsmåder til forudsigelse af medicinrespons |
US9566012B2 (en) | 2014-10-27 | 2017-02-14 | Medtronic, Inc. | Method and apparatus for selection and use of virtual sensing vectors |
US9725769B1 (en) | 2016-10-07 | 2017-08-08 | Oncology Venture ApS | Methods for predicting drug responsiveness in cancer patients |
AU2017258901A1 (en) | 2016-12-30 | 2018-07-19 | Allarity Therapeutics Europe ApS | Methods for predicting drug responsiveness in cancer patients |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4423145A (en) * | 1981-05-07 | 1983-12-27 | Stampfer Martha R | Enhanced growth medium and method for culturing human mammary epithelial cells |
US4668618A (en) | 1981-09-14 | 1987-05-26 | Thornthwaite Jerry T | Nuclear isolation medium and procedure for separating cell nuclei |
US4937187A (en) * | 1983-02-04 | 1990-06-26 | Brown University Research Foundation | Methods for separating malignant cells from clinical specimens |
US4559299A (en) * | 1983-02-04 | 1985-12-17 | Brown University Research Foundation Inc. | Cytotoxicity assays in cell culturing devices |
US4816395A (en) * | 1985-12-19 | 1989-03-28 | Peralta Cancer Research Institute | Method for predicting chemosensitivity of anti-cancer drugs |
US5266480A (en) | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
US4996145A (en) * | 1987-10-27 | 1991-02-26 | Oncotech Incorporated | Method for detecting immune-mediated cytotoxicity |
US5242806A (en) * | 1990-05-07 | 1993-09-07 | Baxter Diagnostics Inc. | Method for conducting the cytotoxicity assays on tumor cells |
US5874218A (en) | 1990-06-11 | 1999-02-23 | Nexstar Pharmaceuticals, Inc. | Method for detecting a target compound in a substance using a nucleic acid ligand |
US5270172A (en) * | 1991-04-26 | 1993-12-14 | Dekk-Tek, Inc. | Method to predict tumor response to therapy |
US5407653A (en) * | 1991-06-26 | 1995-04-18 | Brigham And Women's Hospital | Evaluation of the multidrug resistance phenotype |
CA2121129A1 (en) * | 1991-10-29 | 1993-05-13 | Patrick Soon-Shiong | Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release |
WO1994000470A1 (en) | 1992-06-30 | 1994-01-06 | The Wistar Institute Of Anatomy And Biology | DEVELOPMENTAL EMBRYONIC MOUSE cDNA LIBRARIES |
GB9419716D0 (en) | 1994-09-30 | 1994-11-16 | Gearey David | Electrochemical assessment of cell behaviour and metabolic activity |
US5607918A (en) | 1995-03-01 | 1997-03-04 | Ludwig Institute For Cancer Research | Vascular endothelial growth factor-B and DNA coding therefor |
US5888765A (en) | 1995-06-23 | 1999-03-30 | President And Fellows Of Harvard College | Endothelial-cell specific promoter |
US6020473A (en) | 1995-08-25 | 2000-02-01 | Genentech, Inc. | Nucleic acids encoding variants of vascular endothelial cell growth factor |
US5942385A (en) * | 1996-03-21 | 1999-08-24 | Sugen, Inc. | Method for molecular diagnosis of tumor angiogenesis and metastasis |
US6416967B2 (en) * | 1996-07-12 | 2002-07-09 | Precision Therapeutics, Inc. | Method of using multicellular particulates to analyze malignant or hyperproliferative tissue |
US5728541A (en) | 1996-07-12 | 1998-03-17 | Precision Therapeutics, Inc. | Method for preparing cell cultures from biologial specimens for chemotherapeutic and other assays |
US20040072722A1 (en) | 2002-10-10 | 2004-04-15 | Kornblith Paul L. | Methods for assessing efficacy of chemotherapeutic agents |
US20020168679A1 (en) * | 1998-06-11 | 2002-11-14 | Gregory J. Naus | Staining agents and protocols for characterizing malignant cells in culture |
US20040023375A1 (en) * | 2002-07-30 | 2004-02-05 | Precision Therapeutics, Inc. | Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays |
US6008007A (en) * | 1997-01-31 | 1999-12-28 | Oncotech, Inc. | Radiation resistance assay for predicting treatment response and clinical outcome |
US5840507A (en) * | 1997-03-19 | 1998-11-24 | Oncotech, Inc. | Methods for cancer prognosis and diagnosis |
US5972639A (en) * | 1997-07-24 | 1999-10-26 | Irori | Fluorescence-based assays for measuring cell proliferation |
US6074874A (en) | 1997-08-29 | 2000-06-13 | University Of Pittsburgh | Epithelial cell cultures for in vitro testing |
US6111092A (en) * | 1998-06-03 | 2000-08-29 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules encoding DRT111 and uses thereof |
US6664062B1 (en) * | 1998-07-20 | 2003-12-16 | Nuvelo, Inc. | Thymidylate synthase gene sequence variances having utility in determining the treatment of disease |
US6335170B1 (en) * | 1999-02-22 | 2002-01-01 | Torben F. Orntoft | Gene expression in bladder tumors |
EP1059352A1 (de) | 1999-06-08 | 2000-12-13 | Oncodia AG | Langzeitkultur humaner Karzinome |
WO2001033228A2 (en) * | 1999-11-03 | 2001-05-10 | Oncotech, Inc. | Cancer diagnosis employing cell-sorting and gene-profiles |
AU1760001A (en) * | 1999-11-10 | 2001-06-06 | Quest Diagnostics Investments Incorporated | Use of computationally derived protein structures of genetic polymorphisms in pharmacogenomics and clinical applications |
AU2001240998A1 (en) * | 2000-03-06 | 2001-09-17 | Technion Research And Development Foundation Ltd. | Method of and kit for assessing responsiveness of cancer patients to antifolate chemotherapy |
ES2373488T3 (es) * | 2000-04-18 | 2012-02-06 | Virco Bvba | Métodos para medir la resistencia a los fármacos frente a hcv. |
AU2002224435A1 (en) | 2000-10-18 | 2002-04-29 | Precision Therapeutics, Inc. | Method for tandem genomic/proteomic analyses of proliferating cells |
DE60234440D1 (de) * | 2001-01-12 | 2009-12-31 | Univ Washington | Mdr1-varianten und verfahren zu ihrer verwendung |
US20040086888A1 (en) | 2001-10-18 | 2004-05-06 | Kornblith Paul L | Method for tandem genomic/proteomic analysis of proliferating cells |
JP3923366B2 (ja) * | 2001-10-24 | 2007-05-30 | 財団法人癌研究会 | 細胞の抗癌剤感受性の判定法 |
AU2002352799A1 (en) * | 2001-11-20 | 2003-06-10 | Oncomedx, Inc. | Methods for evaluating drug-resistance gene expression in the cancer patient |
AU2006287175A1 (en) | 2005-09-01 | 2007-03-08 | Precision Therapeutics, Inc. | Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics |
-
2003
- 2003-01-02 US US10/336,659 patent/US20040072722A1/en not_active Abandoned
- 2003-10-10 EP EP03779093A patent/EP1556515B1/de not_active Expired - Lifetime
- 2003-10-10 AU AU2003285866A patent/AU2003285866A1/en not_active Abandoned
- 2003-10-10 DE DE60330266T patent/DE60330266D1/de not_active Expired - Lifetime
- 2003-10-10 WO PCT/US2003/032285 patent/WO2004035833A1/en not_active Application Discontinuation
- 2003-10-10 AT AT03779093T patent/ATE449869T1/de not_active IP Right Cessation
-
2007
- 2007-03-05 US US11/713,662 patent/US7575868B2/en not_active Expired - Fee Related
-
2009
- 2009-07-28 US US12/510,671 patent/US7829288B2/en not_active Expired - Fee Related
-
2010
- 2010-10-05 US US12/898,232 patent/US8039213B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1556515A4 (de) | 2007-11-07 |
US20080032298A1 (en) | 2008-02-07 |
US20110020826A1 (en) | 2011-01-27 |
ATE449869T1 (de) | 2009-12-15 |
EP1556515A1 (de) | 2005-07-27 |
US7575868B2 (en) | 2009-08-18 |
AU2003285866A1 (en) | 2004-05-04 |
US20040072722A1 (en) | 2004-04-15 |
EP1556515B1 (de) | 2009-11-25 |
US20090286255A1 (en) | 2009-11-19 |
WO2004035833A1 (en) | 2004-04-29 |
US8039213B2 (en) | 2011-10-18 |
US7829288B2 (en) | 2010-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60330266D1 (de) | Verfahren zur beurteilung der wirksamkeit von chemotherapeutika | |
DE602004027761D1 (de) | Verfahren zum Auswählen und Aufnehmen von Tierzellenkolonien | |
ATE513550T1 (de) | Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung | |
DK1597391T3 (da) | Anvendelse af intron-RNA til måling af genekspression | |
DE60233574D1 (de) | Verfahren und zusammensetzungen zum nachweis des aktivierungszustands multipler proteine in einzelzellen | |
ATE484231T1 (de) | Vorrichtung für vorhersage von muskel/skelett- erkrankungen | |
EA200800879A1 (ru) | Агонисты ppar гамма для улучшения когнитивной функции у apoe4 отрицательных пациентов | |
EA200800951A1 (ru) | Устройство и способ для оценивания ценностного показателя рабочего процесса и определения разрывов в текущем и желаемом состояниях | |
ATE488763T1 (de) | Verfahren zur identifizierung von sich auf einen zellzustand auswirkenden bedingungen | |
ATE482398T1 (de) | Verfahren zur stratifizierung von herzinsuffizienz | |
DK1509618T3 (da) | Autoimmune sygdomme og NADPH-oxidasedefekter | |
MXPA05008793A (es) | Metodos para la prediccion de posibilidad de suicidio durante el tratamiento. | |
WO2005006949A3 (en) | Methods for predicting development of auto-immune diseases and treatment of same | |
DE60211958D1 (de) | Schwefelhaltiger automatenstahl | |
ATE543429T1 (de) | Verfahren zur bestimmung des sympathikus-tonus und messsystem dafür | |
ATE463562T1 (de) | Lp-pla2-aktivitätstest mit hohem durchsatz | |
ATE358673T1 (de) | Nf-kb-inhibitoren | |
DE502004011753D1 (de) | Verwendung von pit-emulsionen in enzymatischen reaktionen | |
DE60326773D1 (de) | Peptid-deformylase-hemmer | |
ATE400814T1 (de) | Pin1 als stadiumsmarker der aggressivität und/oder der metastasierung abnormale zellwachstum | |
ATE408712T1 (de) | Verfahren zur bestimmung des wiederauftretens von prostata krebs | |
ATE489483T1 (de) | Assoziation von pde4d-allelvarianten mit schlaganfall | |
ATE521893T1 (de) | P66-shc als prädiktiver marker bei der krebsbehandlung | |
ATE405828T1 (de) | Biomarker zur reaktionsüberwachung von cdk- hemmern in der klinik | |
ATE438859T1 (de) | Hemmung der s6-kinase-aktivität zur behandlung von insulinresistenz |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |